upper limb functions
Showing 9951 - 9975 of >10,000
Educational Activities Trial in New York (Education program)
Recruiting
- Educational Activities
- Education program
-
New York, New YorkColumbia University
Jan 25, 2021
Critical Illness, Muscle Weakness, Muscle Damage Trial in Amsterdam (Titration of support level)
Completed
- Critical Illness
- +4 more
- Titration of support level
-
Amsterdam, Noord-Holland, NetherlandsVU University medical center
Mar 17, 2021
Cancer Patients First-ever Acute Ischemic Stroke Trial in United States (Enoxaparin, Aspirin)
Completed
- Cancer Patients First-ever Acute Ischemic Stroke
-
Basking Ridge, New Jersey
- +6 more
Aug 6, 2020
Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)
Completed
- Dedifferentiated Liposarcoma
- Selinexor
- Placebo
-
Los Angeles, California
- +70 more
Jan 5, 2023
Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)
Active, not recruiting
- Nonsmall Cell Lung Cancer
-
Anaheim, California
- +9 more
Dec 27, 2022
Abnormal Uterine Bleeding and Progestin-only Contraceptives
Completed
- Contraception
- Depot medroxy-progesterone acetate
- +2 more
-
Assiut, EgyptWomen Health Hospital - Assiut university
Dec 15, 2020
Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))
Completed
- Renal Cell Cancer
- Avelumab (MSB0010718C)
- Axitinib (AG-013736)
-
Scottsdale, Arizona
- +20 more
Dec 6, 2021
Stroke Trial in Kaposvár (Neurorehabilitation, Physiotherapy)
Completed
- Stroke
- Neurorehabilitation
- Physiotherapy
-
Kaposvár, Somogy, HungaryDr. József Tollár
Oct 13, 2020
Lymphoma, Mantle- Cell Trial in United States (Everolimus)
Completed
- Lymphoma, Mantle- Cell
-
Multiple Locations, Arizona
- +30 more
Apr 30, 2021
Metastatic Malignant Tumor to Brain Trial in Taipei (Conformal Whole Brain Radiotherapy with Unilateral Hippocampal Avoidance,
Recruiting
- Metastatic Malignant Neoplasm to Brain
- Conformal Whole Brain Radiotherapy with Unilateral Hippocampal Avoidance
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 14, 2021
Suicidal Poisoning in Emergency Units
Not yet recruiting
- Poisoning
- Questionnaire
-
Assiut, EgyptAssiut University Hospital
Feb 10, 2020
Diabetes Trial in United States (CLBS03 Low Dose, CLBS03 High Dose, Placebo)
Completed
- Diabetes Mellitus
- CLBS03 Low Dose
- +2 more
-
San Diego, California
- +14 more
Dec 14, 2020
Hemophilia Trial in Madrid (Experimental group)
Completed
- Hemophilia
- Experimental group
-
Madrid, Madird, SpainRoyal Victoria Eugenia Foundation
Feb 25, 2019
Myofascial Pain Syndrome of Neck Trial in Istanbul (Capacitive-Resistive Therapy)
Completed
- Myofascial Pain Syndrome of Neck
- Capacitive-Resistive Therapy
-
Istanbul, TurkeyIstanbul University Faculty of Medicine Sports Medicine Departme
May 21, 2020
Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)
Completed
- Urothelial Carcinoma
- Bladder Cancer
- Placebo
- Pembrolizumab
-
Phoenix, Arizona
- +27 more
Sep 16, 2022
Hypercalcemia After Paraffin Oil Injection
Unknown status
- Hypercalcemia
- Granuloma
- Biochemical observational
-
Herlev, DenmarkHerlev Hospital
Oct 6, 2020
Intermittent Claudication Trial in Argentina, United States (Placebo, Sapropterin DiHCl)
Completed
- Intermittent Claudication
- Placebo
- Sapropterin Dihydrochloride
-
Scottsdale, Arizona
- +19 more
Dec 14, 2020
Gastric Cancer Trial in Tokyo (AI-based diagnosis, The expert endoscopists-based diagnosis)
Completed
- Gastric Cancer
- AI-based diagnosis
- The expert endoscopists-based diagnosis
-
Tokyo, JapanDepartment of Gastroenterology, Graduate School of Medicine, The
Nov 19, 2019
Determinants of Penumbra in Acute Ischemic Stroke Patients
Completed
- Acute Ischemic Stroke
-
Haifa, IsraelRambam Health Care Campus
Jun 11, 2020
Salivary Cancer Trial in United States (enzalutamide)
Active, not recruiting
- Salivary Cancer
-
Anchorage, Alaska
- +286 more
Oct 6, 2021
Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Urothelial Carcinoma Associated 1 RNA, Human
- Pembrolizumab
- +3 more
- (no location specified)
Aug 18, 2022